Acute Exacerbation of Idiopathic Pulmonary Fibrosis

Mostrar otras versiones (1)

Acute exacerbation (AEx) of idiopathic pulmonary fibrosis (IPF) is a clinically important complication of IPF that carries a high morbidity and mortality. In the last decade we have learned much about this event, but there are many remaining questions: What is it? Why does it happen? How can we prev...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Joyce S., Collard, Harold R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7122232/
http://dx.doi.org/10.1007/978-3-319-99975-3_17
_version_ 1783515372771606528
author Lee, Joyce S.
Collard, Harold R.
author_facet Lee, Joyce S.
Collard, Harold R.
author_sort Lee, Joyce S.
collection PubMed
description Acute exacerbation (AEx) of idiopathic pulmonary fibrosis (IPF) is a clinically important complication of IPF that carries a high morbidity and mortality. In the last decade we have learned much about this event, but there are many remaining questions: What is it? Why does it happen? How can we prevent it? How can we treat it? This chapter attempts to summarize and update our current understanding of the epidemiology, etiology, and management of acute exacerbation of IPF and point out areas where additional data are needed.
format Online
Article
Text
id pubmed-7122232
institution National Center for Biotechnology Information
language English
publishDate 2018
record_format MEDLINE/PubMed
spelling pubmed-71222322020-04-06 Acute Exacerbation of Idiopathic Pulmonary Fibrosis Lee, Joyce S. Collard, Harold R. Idiopathic Pulmonary Fibrosis Article Acute exacerbation (AEx) of idiopathic pulmonary fibrosis (IPF) is a clinically important complication of IPF that carries a high morbidity and mortality. In the last decade we have learned much about this event, but there are many remaining questions: What is it? Why does it happen? How can we prevent it? How can we treat it? This chapter attempts to summarize and update our current understanding of the epidemiology, etiology, and management of acute exacerbation of IPF and point out areas where additional data are needed. 2018-12-15 /pmc/articles/PMC7122232/ http://dx.doi.org/10.1007/978-3-319-99975-3_17 Text en © Springer Nature Switzerland AG 2019 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Article
Lee, Joyce S.
Collard, Harold R.
Acute Exacerbation of Idiopathic Pulmonary Fibrosis
title Acute Exacerbation of Idiopathic Pulmonary Fibrosis
title_full Acute Exacerbation of Idiopathic Pulmonary Fibrosis
title_fullStr Acute Exacerbation of Idiopathic Pulmonary Fibrosis
title_full_unstemmed Acute Exacerbation of Idiopathic Pulmonary Fibrosis
title_short Acute Exacerbation of Idiopathic Pulmonary Fibrosis
title_sort acute exacerbation of idiopathic pulmonary fibrosis
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7122232/
http://dx.doi.org/10.1007/978-3-319-99975-3_17
work_keys_str_mv AT leejoyces acuteexacerbationofidiopathicpulmonaryfibrosis
AT collardharoldr acuteexacerbationofidiopathicpulmonaryfibrosis

Ejemplares similares